Engene Holdings Inc. · DUS:S0N
BVF PARTNERS L P/IL's stake in Engene Holdings Inc. fell to 1.80% (Schedule 13G/A)
Event Jan 27, 2025 · Filed Jan 29, 2025
BVF PARTNERS L P/IL's stake in Engene Holdings Inc. fell to 1.80%, 945,402 shares, as a passive investor on Jan 27, 2025. Filed Jan 29, 2025 (Schedule 13G/A).
- Stake
- 1.80%
- Shares
- 945,402
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 1.00% | 505,835 |
| BVF I GP LLC | 1.00% | 505,835 |
| BIOTECHNOLOGY VALUE FUND II LP | 0.70% | 383,352 |
| BVF II GP LLC | 0.70% | 383,352 |
| Biotechnology Value Trading Fund OS LP | 0.10% | 43,786 |
| BVF Partners OS Ltd. | 0.10% | 43,786 |
| BVF GP HOLDINGS LLC | 1.70% | 889,187 |
| BVF PARTNERS L P/IL | 1.80% | 945,402 |
| BVF INC/IL | 1.80% | 945,402 |
| LAMPERT MARK N | 1.80% | 945,402 |
Source
Related
- Engene Holdings Inc.
- Bvf Partners L P
- Engene Holdings Inc. shareholders
- Schedule 13G/A · Bvf Partners L P · Jan 29, 2025
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G · Anders Hove · Jul 22, 2026
- Schedule 13G/A · Cormorant Asset Management, LP · May 15, 2026
- Schedule 13G/A · Braden M Leonard · May 14, 2026